indispensable, incisive, innovative
EvaluatePharma® is the premier source for pharma and biotech analysis delivering exclusive, trusted commercial insight into industry performance for over 10 years. We help you find value in the sector through indispensable, incisive and innovative global analysis.
As the first company to provide consensus forecasts on global drug sales, EvaluatePharma set new industry standards in providing reliable consensus estimates for the pharma and biotech industries. Our expertise and innovative approach has led to other pioneering developments including Merge Company tool, Calendar of Events, interactive NPV Analyzer and Sales by Indication.
Whether you have products available to out-license or are looking for new licensing opportunities our new Partnering Opportunities service will make finding your next licensing partner easier. Partnering Opportunities features the latest assets available for partnering presented in their commercial context alongside EvaluatePharma's unique industry analysis. EvaluatePharma® Clinical Trials is our latest development and simplifies complex analysis of the global clinical trials landscape to give you the very latest intelligence you can rely on.
But it's not just our expertise that sets us apart from the rest; the exceptional quality of our data and depth of coverage provide clients with analysis and insights simply not available anywhere else. From Business Development and Licensing right through to Investment Banking, EvaluatePharma offers cutting-edge solutions to increase your competitive edge in the pharma and biotech sector.
Discover why EvaluatePharma is trusted and relied upon by the top global pharma and biotech companies, the investment community and the leading global management consulting firms:
i n d i s p e n s a b l e i n c i s i v e i n n o v a t i v e